These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3702863)

  • 1. The binding of L-[3H]nicotine to a single class of high affinity sites in rat brain membranes.
    Lippiello PM; Fernandes KG
    Mol Pharmacol; 1986 May; 29(5):448-54. PubMed ID: 3702863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of putative high affinity nicotinic receptors on cultured cortical neurons.
    Lippiello PM; Fernandes KG
    J Pharmacol Exp Ther; 1988 Jul; 246(1):409-16. PubMed ID: 3292757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics and mechanism of L-[3H]nicotine binding to putative high affinity receptor sites in rat brain.
    Lippiello PM; Sears SB; Fernandes KG
    Mol Pharmacol; 1987 Apr; 31(4):392-400. PubMed ID: 3574288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
    Khan IM; Yaksh TL; Taylor P
    J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain nicotinic acetylcholine receptors. Biochemical characterization by neosurugatoxin.
    Yamada S; Isogai M; Kagawa Y; Takayanagi N; Hayashi E; Tsuji K; Kosuge T
    Mol Pharmacol; 1985 Aug; 28(2):120-7. PubMed ID: 2862574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological properties of nicotinic acetylcholine receptors on adrenal chromaffin cells and their modification by hypoxic exposure.
    Miwa S; Lee K; Narumiya S
    Yakubutsu Seishin Kodo; 1993 Jun; 13(3):119-28. PubMed ID: 8237127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate.
    Marks MJ; Collins AC
    Mol Pharmacol; 1982 Nov; 22(3):554-64. PubMed ID: 7155123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding differences between nicotine and alpha-bungarotoxin in the rat brain.
    Nukina I; Ogawa N; Takayama H; Ota Z
    Res Commun Chem Pathol Pharmacol; 1985 Jan; 47(1):141-4. PubMed ID: 2858912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]Nicotine binding in rat brain: alteration after chronic acetylcholinesterase inhibition.
    Costa LG; Murphy SD
    J Pharmacol Exp Ther; 1983 Aug; 226(2):392-7. PubMed ID: 6875853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
    D'Amato RJ; Largent BL; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain.
    Bencherif M; Fowler K; Lukas RJ; Lippiello PM
    J Pharmacol Exp Ther; 1995 Nov; 275(2):987-94. PubMed ID: 7473192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.
    Marks MJ; Stitzel JA; Romm E; Wehner JM; Collins AC
    Mol Pharmacol; 1986 Nov; 30(5):427-36. PubMed ID: 3534542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve growth factor enhances [3H]nicotine binding to a nicotinic cholinergic receptor on PC 12 cells.
    Madhok TC; Sharp BM
    Endocrinology; 1992 Feb; 130(2):825-30. PubMed ID: 1733730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes.
    Itzhak Y; Hiller JM; Simon EJ
    Mol Pharmacol; 1985 Jan; 27(1):46-52. PubMed ID: 3965930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of nicotinic receptors on cultured cortical neurons using anti-idiotypic antibodies and ligand binding.
    Lippiello PM; Fernandes KG; Langone JJ; Bjercke RJ
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1216-24. PubMed ID: 2046025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin modulation of presynaptic nicotinic acetylcholine receptors in the rat vas deferens.
    Markus RP; Zago WM; Carneiro RC
    J Pharmacol Exp Ther; 1996 Oct; 279(1):18-22. PubMed ID: 8858970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of [3H]ABT-418: a novel cholinergic channel ligand.
    Anderson DJ; Williams M; Pauly JR; Raszkiewicz JL; Campbell JE; Rotert G; Surber B; Thomas SB; Wasicak J; Arneric SP
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1434-41. PubMed ID: 7791118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of high-affinity nicotinic [3H]acetylcholine binding sites.
    Lukas RJ
    J Pharmacol Exp Ther; 1990 Apr; 253(1):51-7. PubMed ID: 2329523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and pharmacological characterization of somatostatin receptors in rat lung.
    Schloos J; Raulf F; Hoyer D; Bruns C
    Br J Pharmacol; 1997 Jul; 121(5):963-71. PubMed ID: 9222554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination and characterization of a cannabinoid receptor in rat brain.
    Devane WA; Dysarz FA; Johnson MR; Melvin LS; Howlett AC
    Mol Pharmacol; 1988 Nov; 34(5):605-13. PubMed ID: 2848184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.